(PharmaNewsWire.Com, May 05, 2017 ) According to Publisher, the Global Infusion Pumps Market is accounted for $7.5 billion in 2015 and is expected to reach $11.4 billion by 2022 growing at a CAGR of 6.18% from 2015 to 2022. Growing number of aging population, increasing usage of wireless connectivity, increasing demand for smart wearable pumps and increasing surgical procedures are the major factors favoring the infusion pumps market. However, safety risks, government regulatory requirements for updated products, growing number of product recalls due to design flaws and huge R&D costs are expected to restrain the market growth over the forecast period. Moreover, growing adoption of infusion systems act as an opportunity for this market and on the other hand, lack of awareness and growing incidence of prescription errors are the key challenges in this market growth.
Some of the key players in this market include are Symbios Medical LLC., CareFusion Corporation, Moog Inc., B. Braun Melsungen Ag, Terumo Corporation, Johnson & Johnson, Baxter International Inc, Zyno Medical LLC, Roche Diagnostics, Becton, Dickinson and Company (BD), Universal Medical Technologies Inc., Hospira, Inc236 , Smiths Medical, Medtronic PLC and Fresenius Se & Co. KGAA.
Regions Covered -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
